I Holland offers free trial of its innovative tool management system
System allows tablet manufacturers to keep a record of tablet quantities by number of tablets, work order or batch information to ensure production is run efficiently.
I Holland is giving its customers the opportunity to sample its innovative IH-TMS, which allows proactive monitoring of tool rotations and tooling inventory and maintenance.
IH-TMS software has been specifically developed to maintain efficient, well-organised and in-depth monitoring of tablet production, an extremely important procedure in pharmaceutical tablet manufacture. Without a system that controls the process effectively, there can be adverse effects to the bottom line.
To demonstrate just how well the system works, I Holland is giving its customer’s a trial copy. Andy Dumelow, I Holland’s PharmaCare® Product Manager explains: “We wanted to show just how easy IH-TMS is to incorporate into a company’s manufacturing process, and how well it performs on monitoring and managing tooling. For a limited time, we are giving customers the opportunity to try the software for free so they can see first-hand how much of a difference it makes in improving their current system.
“The stand-alone system allows tablet manufacturers to keep a record of tablet quantities by number of tablets, work order or batch information to ensure production is run efficiently. It also incorporates an in-depth guide to tooling specification and troubleshooting so any problems flagged up by IH-TMS can be rectified. In addition, it has the capability to archive tablet and tool images and drawings and incorporates an alarm to alert users of any problems including over compression, tooling replacements or when maintenance is required.
“The free demonstration is open to companies from around the world and incorporates the flexibility of using any language, including characters used in, for example, Japanese, Chinese, Arabic and Russian making it a globally diverse management system.”
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance